Point of Care Diagnostics Market Will Rise to Almost $3 Billion by 2021, says GlobalData



Point of care (POC) diagnostics market will expand from $2.13 billion in 2015 to almost $3 billion by 2021, primarily due to increase in lifestyle-related and infectious diseases

In addition to this, POC device sales will be driven by their potential to accelerate patient care decision-making and reduce the length of hospital stays, says analyst

Point of Care Diagnostics Market Will Rise to Almost $3 Billion by 2021, says GlobalData

LONDON, UK (GlobalData), 8 March 2016 - The point of care (POC) diagnostics market will experience solid growth from $2.13 billion in 2015 to just under $3 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 5.3%, according to research and consulting firm GlobalData.

The company's latest report* states that such growth, which will occur across the 10 major markets (10MM) of the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil, will be driven by a number of factors, including the increasing prevalence of lifestyle-related and infectious diseases.

Other market drivers include the increasing adoption of cardiac markers in emergency departments, the growing home-testing market, and the potential for POC devices to accelerate patient care decision-making and reduce overall hospital lengths of stay.

Wenlu Hu, GlobalData's Analyst covering Medical Devices, says: "Particularly important in the growth of the POC market is the emergence of more accurate molecular POC technologies for infectious disease testing.

"GlobalData forecasts that the market for cardiac markers POC tests, which can assist with the diagnosis of conditions such as acute coronary syndrome, will reach $507.5 million by 2021, due to the tests' ability to shorten emergency department stays, allowing for faster discharge of patients and reduced costs."

Beyond hospitals and healthcare facilities, home-testing medical devices are also on the rise, as the penetration and expansion of POC tests into the over-the-counter (OTC) consumer market is substantially driving market growth.

Hu explains: "The adoption of these tests began when technologies were first being developed to allow diabetics to monitor their blood glucose levels using simple handheld meters. Many new tests are available in OTC formats, including meters for anticoagulation monitoring, urine pregnancy tests, and fertility tests.

"In line with the OTC pharmaceutical market, the trend towards POC home testing will most likely continue to expand, possibly into areas such as concussions, reflecting a greater awareness of consumerism in the laboratory testing market."

*MediPoint: Point of Care Diagnostics – Global Analysis and Market Forecasts



This report provides analysis of the point of care diagnostics space across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India, including annualized market data from 2015 and forecast until 2021.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData's team of industry experts.

For guidelines on how to cite GlobalData, please see: http://www.globaldata.com/QuotingGlobalData.aspx


GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For more information, please contact our Press Office on +44 (0)1204 543 537 or at pr@globaldata.com.